OSTEOPOROSIS - Key Persons
Job Titles:
- QSO ) MA ( Hons ), MPP ( Dist ), CFInstD
Christine is the Executive Director of Osteoporosis New Zealand.
After graduating from Massey University with a BSC (Biochem), Christine started her career as a member of the Connective Tissue Research Group, Department of Surgery, at Auckland University's School of Medicine.
Following some years gathering experience in the infant nutritional and pharmaceutical sectors, Christine held the position of General Manager of Horleys where she and her team developed a number of nutritional products targeting specific demographics within the market.
For the past decade Christine has co-founded Flavorjen - a company providing innovation through the incorporation of specialised ingredients into the food and beverage manufacturing sector.
David is an Auckland trained consultant endocrinologist and physician at Waitemata District Health Board, and is the clinical leader for General Medicine at Waitakere Hospital. He is the lead clinician for the fracture liaison service at Waitemata DHB, and his clinical and research interests include osteoporosis, diabetes, obesity and bariatric medicine.
Mike practices as a diagnostic radiologist in Wellington. He was the Senior Lecturer in Radiology at the Wellington School of Medicine and Health Science and has many years of teaching and research experience. Mike is now serving a third term as a member of the board of Osteoporosis NZ. Working daily with patients' bone density scans he brings a practical patient focused perspective to the board.
Stella is consultant reproductive endocrinologist to National Womens' Hospital, Auckland and for the Reproductive Endocrine group, Fertility Associates Auckland, and a senior clinical lecturer in the Department of Obstetrics and Gynaecology at the University of Auckland.
She is the Chairman of the Specialist advisory committee in endocrinology for the Royal Australasian College of Physicians, a member of the New Zealand Guideline Committees for Menopausal Hormone therapy and Fertility Preservation, an advisor to Pharmac NZ, and the New Zealand Medical Council, and on the Boards of Human Fertility UK and Osteoporosis NZ. Her clinical and research interests include polycystic ovary syndrome, anovulatory infertility, hypothalamic amenorrhea, menopause, and osteoporosis.
Job Titles:
- Distinguished Professor in Medicine at the University of Auckland
Ian Reid MD is a Distinguished Professor in Medicine at the University of Auckland, where he is Deputy Dean of the Faculty of Medical and Health Sciences. His research interests include calcium metabolism, vitamin D and osteoporosis. He is a past-president of the International Bone and Mineral Society (IBMS), and a recipient of research awards from the American Society of Bone & Mineral Research, the IBMS, the European Calcified Tissue Society, the Health Research Council of New Zealand, the Royal Society of New Zealand (Rutherford Medal) and of the New Zealand Prime Minister's Science Prize.
Job Titles:
- Member of the Board
- Marketing Strategist
Jan is a marketing strategist with a solid background in media and communications; launching and sustaining some of New Zealand's best-known brands, PR (media relations), marketing, sponsorship, charity fundraising and business development.
Job Titles:
- Chief Executive
- Member of the Board
Lynne is a current chief executive and has held various senior management positions in the Wellington corporate arena. She is a qualified Chartered Accountant and a member of the Institute of Chartered Accountants as well as a member of the Institute of Directors of NZ. Lynne brings her knowledge of senior management and governance experience to the Osteoporosis NZ Board. She currently serves on 2 commercial boards of NZ companies, and has served on other charitable boards from time to time.
Paul has spent the last 20 years working on programs to improve fragility fracture care and prevention throughout the world. Paul has published extensively on implementation of Fracture Liaison Services and was an author of the 2012 International Osteoporosis Foundation World Osteoporosis Day Report on the ‘Capture the Fracture' Campaign. He is Managing Director of Synthesis Medical NZ Limited, an Adjunct Senior Lecturer at the University of Notre Dame Australia and a member of the ANZ Hip Fracture Registry Steering Group. Paul served as Board Chairman of the Board of Trustees of Osteoporosis NZ between March 2014 and June 2018.
Job Titles:
- Chairman of the Board
- Chief Executive at Leukaemia & Blood Cancer New Zealand
Peter is currently Chief Executive at Leukaemia & Blood Cancer New Zealand. He brings with him over twenty years of CEO and governance experience in the commercial, health, sporting and disability sectors.
Drawn to values-driven organisations that ‘make a difference' in people's lives and are committed to leading their sector, he believes that Osteoporosis New Zealand is a natural fit.
An experienced executive coach and facilitator, developing people, leaders and culture is Sue's passion. Her clients value her positive encouragement, savvy commercial nous and coaching ability. She expertly challenges people and organisations to stretch and grow their capability to achieve their vision and strategy. Woking closely in the public and private sector she brings perspective at the individual and enterprise level that seed fresh thinking..
Sue feels a deep responsibility to contribute to making a better NZ for current and future generations She recognises that a significant challenge exists for leaders to create the environment for others to thrive while delivering short- and long-term organisational results that benefit the communities they are part of.
Sue's credentials include an MSC in Microbiology from Massey University, a Business Diploma from Auckland University. She is accredited in a broad range of globally respected facilitation and leadership tools.
Sue is a keen sailor, and is part of a regular racing crew. She has even been known to take people out sailing on the Waitemata as part of leadership and team development programmes.